WO2014203176A1 - Water soluble compositions for treating hair loss & promoting hair growth - Google Patents

Water soluble compositions for treating hair loss & promoting hair growth Download PDF

Info

Publication number
WO2014203176A1
WO2014203176A1 PCT/IB2014/062353 IB2014062353W WO2014203176A1 WO 2014203176 A1 WO2014203176 A1 WO 2014203176A1 IB 2014062353 W IB2014062353 W IB 2014062353W WO 2014203176 A1 WO2014203176 A1 WO 2014203176A1
Authority
WO
WIPO (PCT)
Prior art keywords
hair growth
composition
water soluble
salt
water
Prior art date
Application number
PCT/IB2014/062353
Other languages
French (fr)
Inventor
Kalvi HEMANTH KUMAR
Ramamoorthy RAJAKUMAR
Koottungalamadhom Ramaswamy RANGANATHAN
Govindarajalu JEYARAMAN
Krishna Damodarprasad BHAMA
Original Assignee
Kop Research Centre Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kop Research Centre Pvt Ltd filed Critical Kop Research Centre Pvt Ltd
Publication of WO2014203176A1 publication Critical patent/WO2014203176A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14Oxygen atoms

Definitions

  • the present invention relates, in general, to a hair growth composition for the treatment of alopecia, or stimulating hair regrowth. More particularly, the present invention relates to a water-soluble composition for hair regrowth, or for the treatment of hair loss, comprising a hair growth stimulant and a multifunctional compound.
  • hair growth and shedding is random and not seasonal or cyclical. At any given time, a random number of hairs will be in one of three stages of growth and shedding: anagen, catagen, and telogen.
  • the anagen phase or growth phase during which the hair lengthens, lasts several years.
  • the catagen phase which succeeds the anagen phase, is very short and lasts only a few weeks.
  • the telogen phase which lasts several months, corresponds to a period of rest of the follicle, where the hair finishes by falling out.
  • the natural loss of the hair can be estimated, on average, at a few hundred hairs per day for a normal physiological state. However, it happens that the hair cycle can go wrong and that hair loss accelerates and results in a temporary or definitive loss of the hair known as alopecia.
  • Hair loss particularly in men, mainly after middle age, can be attributed to several factors or a combination of them.
  • the factors can be medication, genetics, stress, malnutrition, hormonal imbalance, reduced blood flow to hair follicles etc.
  • minoxidil is the only active chemical ingredient that is approved by FDA for generating new hair growth.
  • minoxidil A major disadvantage of minoxidil is that it is practically insoluble in water, which limits its use to such formulations having relatively low proportion of water.
  • Formulations containing high concentrations of alcohol or polyalcohol are in general not well tolerated and alcohol present in topical preparation may dry the scalp resulting in dandruff, rash and itchiness. When the vehicle evaporates, formation of crystalline Minoxidil occurs. But the water- soluble formulation enhances the transdermal delivery or penetration of Minoxidil in comparison with solvent based.
  • the present invention aims to disclose and provide a hair growth composition that is capable of providing required nutrients to hair follicles to stimulate hair growth and prevent hair loss.
  • the composition of the present invention comprises a hair growth stimulant and a multifunctional compound.
  • the present invention also provides a water-soluble composition comprising a hair growth stimulant and a multifunctional compound.
  • the composition of the present invention is intended for topical administration.
  • the present invention further provides a water-soluble salt, which is prepared by combination of a hair growth stimulant and a multifunctional compound.
  • the hair growth stimulant used in the present invention is pyrimidine-3-oxide derivative whereas the multifunctional compound of the present invention is L-2-oxothiazolidine-4-carboxylic acid.
  • the present invention further provides a method for preparing water-soluble salt by reacting a pyrimidine-3-oxide derivative with L-2-oxothiazolidine-4-carboxylic acid in a stoichiometric ratio.
  • the water-soluble salt is prepared using solvents and isolated using conventional techniques such as evaporation of solvent, precipitation with non-solvents etc.
  • the present invention further provides a method for preventing hair loss and stimulating hair regrowth by topically administering a water-soluble composition comprising a hair growth stimulant and a multifunctional compound.
  • a water-soluble composition comprises a pyrimidine-3-oxide derivative and a cyclic amino acid, preferably L-2-oxothiazolidine-4-carboxylic acid.
  • FIG 1 Hair density and hair growth results on Minoxidil 5% (market sample) on subjects tested.
  • FIG. Hair density and hair growth results of water-soluble salt of L-2-oxothiazolidine-4- carboxylic acid with 2,4-Diamino-6-piperidinopyrimidine-3-oxide (Minoxidil) on subjects tested.
  • FIG. Hair density and hair growth results of water-soluble salt of L-2-oxothiazolidine-4- carboxylic acid with 2,4-Diamino-6-pyrrolidinoyrimidine-3-oxide on subjects tested.
  • FIG. Hair density and hair growth results of water-soluble salt of L-2-Oxothiazolidine-4- carboxylic acid with 2,4-Diamino pyrimidine-3-oxide on subjects tested.
  • the present invention is directed to water-soluble compositions for the treatment of alopecia and stimulating hair regrowth.
  • the composition is intended for topical administration and significantly enhances the transdermal delivery of the hair growth stimulant and the multifunctional compound.
  • the multifunctional compound is a cysteine source and a simulator of intracellular glutathione.
  • Cysteine is the major acid component of hair, which plays an important role by contributing to hair growth and hair loss prevention.
  • a water soluble hair growth salt suitable for treating alopecia and stimulate hair growth having a cyclic amino acid and a hair growth stimulant, wherein the cyclic amino acid is preferably L-2-Oxothiazolidine-4-carboxylic acid formula (a), wherein the hair growth stimulant is 2,4- Diamino pyrimidine-3-oxide derivatives of the formula (b).
  • R is either Hydrogen or AlkyI of from 1 to 8 carbon atoms or heterocyclic moieties containing either Nitrogen or Nitrogen and Oxygen.
  • the heterocyclic moiety is selected from a group comprising pyrrolidine, piperidine, piperazine, morpholine.
  • 2,4-Diamino pyrimidine-3-oxide derivatives of the formula (b) is selected from a group comprising 2,4-Diamino-6-piperidinopyrimidine, 2,4-Diamino-6- pyrrolidinopyrimidine, 2,4-Diamino pyrimidine N-oxides.
  • a water-soluble salt having formula (I) is prepared by combination of L-2-oxothiazolidine-4-carboxylic acid and 2, 4-diamino-6- piperidinopyrimidine-3-oxide, generically referred as minoxidil.
  • a water-soluble salt having formula (II) is prepared by combination of L-2-oxothiazolidine-4-carboxylic acid and 2, 4-diamino-6- pyrrolidinopyrimidine-3-oxide.
  • a water-soluble salt having formula (III) is prepared by combination of L-2-oxothiazolidine-4-carboxylic acid and 2, 4-diamono pyrimidine-3-oxide.
  • the multifunctional compound used in the present invention is L-2-oxothiazolidine-4- carboxylic acid, which considerably enhances the properties of hair growth stimulant in treating hair loss and stimulating hair regrowth.
  • L-2-oxothiazolidine-4-carboxylic acid added to the present invention provides necessary ingredients for the healthy growth of hair. Further, L-2- oxothiazolidine-4-carboxylic acid can provide necessary nutrients to increase the strength and stability of hair-scalp bond. Additionally, L-2-oxothiazolidine-4-carboxylic acid being an excellent antioxidant, it can prevent and limit toxic alopecia also.
  • L-2-oxothiazolidine-4-carboxylic acid blocks the formation of dihydro testosterone (DHT), which is the main cause of destruction of hair follicles, by preventing reaction of 5-alpha reductase on the male hormone testosterone.
  • DHT dihydro testosterone
  • water-soluble composition of the present invention contains high percentage of water and enhance the transdermal delivery of the hair growth stimulant and multifunctional compound. Further, it has been observed that the water-soluble composition can also be used in the treatment of alopecia resulting from oxidative stress as L-2-oxothiazolidine-4-carboxylic acid is excellent antioxidant. Moreover, L-2-oxothiazolidine-4-carboxylic acid has been proved to be an excellent radical scavenger and hence the water-soluble composition can also be used in the treatment of alopecia induced by the use of chemotherapeutic agents.
  • the water-soluble composition of the present invention is intended for topical use and can be administered as gel, cream, lotion, ointment, solution or spray.
  • the water-soluble composition may further contain other therapeutic agents and conventionally used vehicles and excipients such as fragrances, stabilizers, colors etc.
  • compositions of the present invention are therapeutically superior to the compositions containing hair growth stimulants alone. This showed marked synergism between the hair growth stimulant and multifunctional compound.
  • Example 3 21 5gm of L-2-Oxothiazolidine-4-carboxylic acid was added to a suspension of 28.5gm of 2,4-Diamino-6-pyrrolidinopyrimidine 3-oxide in 450gm water. The solution becomes clear after stirring for 1 hr. The resulting solution can be used directly for the preparation of compositions suitable for topical applications. The solution was analyzed for the contents present.
  • Table 3 pH of all the above water soluble compositions were adjusted to 4.5 - 5.5 using mild bases (organic / inorganic) known in the art. Open label, phase II, clinical study was carried out, to evaluate the safety and efficacy of topical application of the above 3 compositions and conventional 5% solution of 2,4- Diamino-6-piperidinopyrimidine-3-oxide (Minoxidil) available in market, for the treatment of mild to moderate androgenic alopecia in male patients.
  • Minoxidil 2,4- Diamino-6-piperidinopyrimidine-3-oxide
  • the water soluble salts showed increased mRNA values.
  • the water soluble composition of 2,4-Diamino-6-piperidinopyrimidine-3-oxide (Minoxidil) with L-2-Oxothiazolidine-4-carboxylic acid showed almost 3 times mRNA value when compared with 5% solution of 2,4-Diamino-6-piperidinopyrimidine-3-oxide

Abstract

Provided is water-soluble hair growth compositions for treating alopecia and stimulating hair regrowth, comprising a hair growth stimulant and a multifunctional compound, preferably L-oxothiazolidine-4-carboxylic acid.

Description

WATER SOLUBLE COMPOSITIONS FOR TREATING HAIR LOSS & PROMOTING
HAIR GROWTH
Field of the Invention
The present invention relates, in general, to a hair growth composition for the treatment of alopecia, or stimulating hair regrowth. More particularly, the present invention relates to a water-soluble composition for hair regrowth, or for the treatment of hair loss, comprising a hair growth stimulant and a multifunctional compound.
Background of the Invention
In human beings, hair growth and shedding is random and not seasonal or cyclical. At any given time, a random number of hairs will be in one of three stages of growth and shedding: anagen, catagen, and telogen. The anagen phase or growth phase, during which the hair lengthens, lasts several years. The catagen phase, which succeeds the anagen phase, is very short and lasts only a few weeks. The telogen phase, which lasts several months, corresponds to a period of rest of the follicle, where the hair finishes by falling out.
The natural loss of the hair can be estimated, on average, at a few hundred hairs per day for a normal physiological state. However, it happens that the hair cycle can go wrong and that hair loss accelerates and results in a temporary or definitive loss of the hair known as alopecia.
Hair loss, particularly in men, mainly after middle age, can be attributed to several factors or a combination of them. The factors can be medication, genetics, stress, malnutrition, hormonal imbalance, reduced blood flow to hair follicles etc.
Even though several active ingredients are known for hair loss treatment, minoxidil is the only active chemical ingredient that is approved by FDA for generating new hair growth.
A major disadvantage of minoxidil is that it is practically insoluble in water, which limits its use to such formulations having relatively low proportion of water. Formulations containing high concentrations of alcohol or polyalcohol are in general not well tolerated and alcohol present in topical preparation may dry the scalp resulting in dandruff, rash and itchiness. When the vehicle evaporates, formation of crystalline Minoxidil occurs. But the water- soluble formulation enhances the transdermal delivery or penetration of Minoxidil in comparison with solvent based.
Therefore, although numerous compositions for stimulation of hair growth are known and taught in the art, there is still a need to develop a hair growth composition, which is water- soluble and have superior effects without side effects.
Summary of the Invention
The present invention aims to disclose and provide a hair growth composition that is capable of providing required nutrients to hair follicles to stimulate hair growth and prevent hair loss. The composition of the present invention comprises a hair growth stimulant and a multifunctional compound.
The present invention also provides a water-soluble composition comprising a hair growth stimulant and a multifunctional compound. The composition of the present invention is intended for topical administration.
The present invention further provides a water-soluble salt, which is prepared by combination of a hair growth stimulant and a multifunctional compound. The hair growth stimulant used in the present invention is pyrimidine-3-oxide derivative whereas the multifunctional compound of the present invention is L-2-oxothiazolidine-4-carboxylic acid.
The present invention further provides a method for preparing water-soluble salt by reacting a pyrimidine-3-oxide derivative with L-2-oxothiazolidine-4-carboxylic acid in a stoichiometric ratio. In another aspect of the present invention, the water-soluble salt is prepared using solvents and isolated using conventional techniques such as evaporation of solvent, precipitation with non-solvents etc.
The present invention further provides a method for preventing hair loss and stimulating hair regrowth by topically administering a water-soluble composition comprising a hair growth stimulant and a multifunctional compound. In one aspect of the present invention, a water-soluble composition comprises a pyrimidine-3-oxide derivative and a cyclic amino acid, preferably L-2-oxothiazolidine-4-carboxylic acid. These and other aspects of the present invention will be explained and understood when considered in conjunction with the following detailed description and the accompanying drawings. It should be understood, however, that the following descriptions, while indicating preferred embodiments and numerous specific details thereof, are given by way of illustration and not of limitation.
Brief Description of Accompanied Figures
FIG 1 . Hair density and hair growth results on Minoxidil 5% (market sample) on subjects tested.
FIG 2. Hair density and hair growth results of water-soluble salt of L-2-oxothiazolidine-4- carboxylic acid with 2,4-Diamino-6-piperidinopyrimidine-3-oxide (Minoxidil) on subjects tested.
FIG 3. Hair density and hair growth results of water-soluble salt of L-2-oxothiazolidine-4- carboxylic acid with 2,4-Diamino-6-pyrrolidinoyrimidine-3-oxide on subjects tested.
FIG 4. Hair density and hair growth results of water-soluble salt of L-2-Oxothiazolidine-4- carboxylic acid with 2,4-Diamino pyrimidine-3-oxide on subjects tested.
Detailed Description of the Invention
The present invention is directed to water-soluble compositions for the treatment of alopecia and stimulating hair regrowth. The composition is intended for topical administration and significantly enhances the transdermal delivery of the hair growth stimulant and the multifunctional compound.
According to an embodiment of the present invention, the multifunctional compound is a cysteine source and a simulator of intracellular glutathione. Cysteine is the major acid component of hair, which plays an important role by contributing to hair growth and hair loss prevention.
In an embodiment of the present invention, a water soluble hair growth salt suitable for treating alopecia and stimulate hair growth is provided. The water soluble salt having a cyclic amino acid and a hair growth stimulant, wherein the cyclic amino acid is preferably L-2-Oxothiazolidine-4-carboxylic acid formula (a), wherein the hair growth stimulant is 2,4- Diamino pyrimidine-3-oxide derivatives of the formula (b).
Figure imgf000005_0001
(a) (b)
In above formula (b), wherein the R is either Hydrogen or AlkyI of from 1 to 8 carbon atoms or heterocyclic moieties containing either Nitrogen or Nitrogen and Oxygen. The heterocyclic moiety is selected from a group comprising pyrrolidine, piperidine, piperazine, morpholine.
According to an embodiment, 2,4-Diamino pyrimidine-3-oxide derivatives of the formula (b) is selected from a group comprising 2,4-Diamino-6-piperidinopyrimidine, 2,4-Diamino-6- pyrrolidinopyrimidine, 2,4-Diamino pyrimidine N-oxides.
In another embodiment of the present invention, a water-soluble salt having formula (I) is prepared by combination of L-2-oxothiazolidine-4-carboxylic acid and 2, 4-diamino-6- piperidinopyrimidine-3-oxide, generically referred as minoxidil.
Figure imgf000005_0002
( I )
In yet another embodiment of the present invention, a water-soluble salt having formula (II) is prepared by combination of L-2-oxothiazolidine-4-carboxylic acid and 2, 4-diamino-6- pyrrolidinopyrimidine-3-oxide.
Figure imgf000006_0001
( Π )
In yet another embodiment of the present invention, a water-soluble salt having formula (III) is prepared by combination of L-2-oxothiazolidine-4-carboxylic acid and 2, 4-diamono pyrimidine-3-oxide.
Figure imgf000006_0002
( III )
The multifunctional compound used in the present invention is L-2-oxothiazolidine-4- carboxylic acid, which considerably enhances the properties of hair growth stimulant in treating hair loss and stimulating hair regrowth.
It has been observed that L-2-oxothiazolidine-4-carboxylic acid added to the present invention provides necessary ingredients for the healthy growth of hair. Further, L-2- oxothiazolidine-4-carboxylic acid can provide necessary nutrients to increase the strength and stability of hair-scalp bond. Additionally, L-2-oxothiazolidine-4-carboxylic acid being an excellent antioxidant, it can prevent and limit toxic alopecia also.
Moreover, L-2-oxothiazolidine-4-carboxylic acid blocks the formation of dihydro testosterone (DHT), which is the main cause of destruction of hair follicles, by preventing reaction of 5-alpha reductase on the male hormone testosterone.
In yet another embodiment of the present invention, water-soluble composition of the present invention contains high percentage of water and enhance the transdermal delivery of the hair growth stimulant and multifunctional compound. Further, it has been observed that the water-soluble composition can also be used in the treatment of alopecia resulting from oxidative stress as L-2-oxothiazolidine-4-carboxylic acid is excellent antioxidant. Moreover, L-2-oxothiazolidine-4-carboxylic acid has been proved to be an excellent radical scavenger and hence the water-soluble composition can also be used in the treatment of alopecia induced by the use of chemotherapeutic agents.
In another embodiment, the water-soluble composition of the present invention is intended for topical use and can be administered as gel, cream, lotion, ointment, solution or spray. The water-soluble composition may further contain other therapeutic agents and conventionally used vehicles and excipients such as fragrances, stabilizers, colors etc.
It has been found that the water-soluble compositions of the present invention are therapeutically superior to the compositions containing hair growth stimulants alone. This showed marked synergism between the hair growth stimulant and multifunctional compound.
The examples used herein are intended merely to facilitate an understanding of ways in which the embodiments herein may be practiced and to further enable those skilled in the art, to practice the embodiments herein. Accordingly, the examples should not be construed as limiting the scope of the embodiments herein.
Example 1
20 gm of L-2-Oxothiazolidine-4-carboxylic acid was added to a suspension of 30 gm of 2,4-Diamino-6-piperidinopyrimidine-3-oxide in 450 gm water. The solution becomes clear after stirring for 1 hr. The resulting solution can be used directly for the preparation of compositions suitable for topical applications. The solution was analyzed for the contents present.
Example 2
20 gm of L-2-Oxothiazolidine-4-carboxylic acid and 30 gm of 2,4-Diamino-6- piperidinopyrimidine-3-oxide was dissolved in 1 .0 Itr of 95% alcohol. The solvent was evaporated to give the desired solid. Alternatively the solid can also be obtained by partial distillation of the solvent and precipitation of the same with a suitable solvent. The solid can be analyzed using techniques known in the art.
Example 3 21 .5gm of L-2-Oxothiazolidine-4-carboxylic acid was added to a suspension of 28.5gm of 2,4-Diamino-6-pyrrolidinopyrimidine 3-oxide in 450gm water. The solution becomes clear after stirring for 1 hr. The resulting solution can be used directly for the preparation of compositions suitable for topical applications. The solution was analyzed for the contents present.
Example 4
21 .5 gm of L-2-Oxothiazolidine-4-carboxylic acid and 28.5gm of 2,4-Diamino-6- pyrrolidinopyrimidine-3-oxide was dissolved in 1 .0 Itr of 95% alcohol. The solvent was evaporated to give the desired solid. Alternatively the solid can also be obtained by partial distillation of the solvent and precipitation of the same with a suitable solvent. The solid can be analyzed using techniques known in the art.
Example 5
8.67gm of L-2-Oxothiazolidine-4-carboxylic acid was added to a suspension of 7.33 gm of 2,4-Diamino pyrimidine-3-oxide in 484 gm water. The solution becomes clear after stirring for 1 hr. The resulting solution can be used directly for the preparation of compositions suitable for topical applications. The solution was analyzed for the contents present.
Example 6
8.67gm of L-2-Oxothiazolidine-4-carboxylic acid and 7.33 gm of 2,4-Diamino pyrimidine-3- oxide was dissolved in 1 .0 Itr of 95% alcohol. The solvent was evaporated to give the desired solid. Alternatively the solid can also be obtained by partial distillation of the solvent and precipitation of the same with a suitable solvent. The solid can be analyzed using techniques known in the art.
IR and NMR analysis of all the above salts confirmed their desired structures. Example 7
Composition containing water-soluble salt prepared in Example 1 and 2 is shown in Table 1
Figure imgf000008_0001
Fragrance q.s
Colour q.s
Water q.s to 100
Table 1
Example 8
Composition containing water-soluble salt prepared in Example 3 and 4 is shown in Table 2
Figure imgf000009_0001
Table 2
Example 9
Composition containing water-soluble salt prepared in Example 5 and 6 is shown in Table 3
Figure imgf000009_0002
Table 3 pH of all the above water soluble compositions were adjusted to 4.5 - 5.5 using mild bases (organic / inorganic) known in the art. Open label, phase II, clinical study was carried out, to evaluate the safety and efficacy of topical application of the above 3 compositions and conventional 5% solution of 2,4- Diamino-6-piperidinopyrimidine-3-oxide (Minoxidil) available in market, for the treatment of mild to moderate androgenic alopecia in male patients.
Few research papers disclosed that mRNA levels have been co-related to hair growth. More the mRNA value, better is the effectiveness of the formulation in hair growth.
According to above clinical study, the water soluble salts showed increased mRNA values. Particularly, the water soluble composition of 2,4-Diamino-6-piperidinopyrimidine-3-oxide (Minoxidil) with L-2-Oxothiazolidine-4-carboxylic acid showed almost 3 times mRNA value when compared with 5% solution of 2,4-Diamino-6-piperidinopyrimidine-3-oxide
(Minoxidil) available in market as shown in Table 4.
Figure imgf000010_0001
Table 4
The foregoing description of the specific embodiments will so fully reveal the general nature of the embodiments herein that others can, by applying current knowledge, readily modify and/or adapt for various applications such specific embodiments without departing from the generic concept, and therefore, such adaptations and modifications are intended to be comprehended within the meaning and range of equivalents of the disclosed embodiments. It is to be understood that the phraseology or terminology employed herein is for the purpose of description and not of limitation. Therefore, while the embodiments herein have been described in terms of preferred embodiments, those skilled in the art will recognize that the embodiments herein can be practiced with modifications within the spirit and scope of the appended claims.

Claims

Claims
A water soluble hair growth salt suitable for treating alopecia and stimulate hair growth, wherein the water soluble salt having a cyclic amino acid and a hair growth stimulant, wherein the cyclic amino acid is preferably L-2-Oxothiazolidine-4- carboxylic acid formula (a), wherein the hair growth stimulant is 2,4-Diamino pyrimidine-3-oxide derivatives of the formula (b).
Figure imgf000011_0001
(a) (b)
2. The water soluble hair growth salt as claimed in claim 1 , wherein R is either
Hydrogen or Alkyl of from 1 to 8 carbon atoms or heterocyclic moieties containing either Nitrogen or Nitrogen and Oxygen.
3. The water soluble hair growth salt as claimed in claim 2, wherein the heterocyclic moieties is selected from a group comprising pyrrolidine, piperidine, piperazine, morpholine.
4. The water soluble hair growth salt as claimed in claim 1 , wherein 2,4-Diamino
pyrimidine-3-oxide derivatives of the formula (b) is selected from a group comprising 2,4-Diamino-6-piperidinopyrimidine, 2,4-Diamino-6- pyrrolidinopyrimidine, 2,4-Diamino pyrimidine N-oxides.
5. A composition suitable for topical application for treating alopecia and stimulate hair growth, wherein the composition comprising a water soluble salt as claimed in claim 1 .
6. The composition as claimed in claim 5, wherein the composition can be
administered in the form of lotion, cream, spray, gel, solution or ointment.
7. The composition as claimed in claim 5, wherein the salt is in the range from 0.1 to 15% of the composition.
8. The composition as claimed in claim 5, wherein the composition contains water up to 95% of the composition.
9. The composition as claimed in claim 5, further comprises pharmaceutically
acceptable vehicles or pharmaceutically acceptable excipients.
10. A process for preparing water soluble salt suitable for treating alopecia and stimulate hair growth, wherein the salt is prepared by reacting stoichiometric quantities of formula (a) and formula (b) in water or organic solvents or in a suitable vehicle.
Figure imgf000012_0001
(a) (b)
PCT/IB2014/062353 2013-06-19 2014-06-18 Water soluble compositions for treating hair loss & promoting hair growth WO2014203176A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2665/CHE/2013 2013-06-19
IN2665CH2013 IN2013CH02665A (en) 2013-06-19 2014-06-18

Publications (1)

Publication Number Publication Date
WO2014203176A1 true WO2014203176A1 (en) 2014-12-24

Family

ID=52104040

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2014/062353 WO2014203176A1 (en) 2013-06-19 2014-06-18 Water soluble compositions for treating hair loss & promoting hair growth

Country Status (2)

Country Link
IN (1) IN2013CH02665A (en)
WO (1) WO2014203176A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108210937A (en) * 2018-02-08 2018-06-29 上海应用技术大学 Pyrrole alkyl amino pyrimidine oxide beta-cyclodextrin base inclusion compound and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047409A (en) * 1985-05-22 1991-09-10 Serono Otc S.A. Compounds for cosmetic-dermatological use and relevant compositions
CA2135227A1 (en) * 1993-11-09 1995-05-10 Dennis I. Goldberg Method for preventing hair loss and stimulating new hair growth
US20040006115A1 (en) * 2000-11-17 2004-01-08 Societe L'oreal S.A. 2-Oxothiazolidine 4-carboxylic acid compounds for promoting desquamation of the skin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047409A (en) * 1985-05-22 1991-09-10 Serono Otc S.A. Compounds for cosmetic-dermatological use and relevant compositions
CA2135227A1 (en) * 1993-11-09 1995-05-10 Dennis I. Goldberg Method for preventing hair loss and stimulating new hair growth
US20040006115A1 (en) * 2000-11-17 2004-01-08 Societe L'oreal S.A. 2-Oxothiazolidine 4-carboxylic acid compounds for promoting desquamation of the skin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108210937A (en) * 2018-02-08 2018-06-29 上海应用技术大学 Pyrrole alkyl amino pyrimidine oxide beta-cyclodextrin base inclusion compound and preparation method thereof

Also Published As

Publication number Publication date
IN2013CH02665A (en) 2015-06-19

Similar Documents

Publication Publication Date Title
FI86598C (en) PENETRATIONSBEFRAEMJANDE VEHIKEL FOER ANVAENDNING I PHARMACEUTICAL COMPOSITION FOER UTVAERTES BRUK.
KR100873664B1 (en) Hair restorer
JPH01308216A (en) Combination of pyrimidine derivative and salicylic acid derivative for inducing and stimulating growth of hair to reduce loss of hair
JP2005314323A (en) Hair growth formulation
JPH08277209A (en) Revitalizing hair tonic
JP4940527B2 (en) Sustainable hair growth composition
JPS6130567A (en) Method of stabilizing urea
KR102281398B1 (en) Formulations containing sphinganine
JPH06501947A (en) 5-Fluoro-2,4,6-pyrimidinetriamine compound
WO2014203176A1 (en) Water soluble compositions for treating hair loss & promoting hair growth
JP2000198719A (en) Hair growing agent
KR101670865B1 (en) Cosmetic or pharmaceutical composition for promoting hair growth containing Sinomenine Hydrochloride
JPWO2001076540A1 (en) Hair restoration composition
KR101651248B1 (en) Cosmetic or pharmaceutical composition for promoting hair growth containing Forsythin
WO2002062422A1 (en) Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof
JPH08113516A (en) Composition for scalp
JP5555922B2 (en) Composition for treating hair loss or delaying the onset of hair loss
KR102000935B1 (en) Cosmetic or pharmaceutical composition for promoting hair growth containing 5-hydroxytryptophan
KR102611504B1 (en) Composition for promoting the hair growth comprising kirenol
KR20170134109A (en) Composition for promoting the hair growth comprising Tabersonine
US20150073005A1 (en) Composition for hair growth
WO2017021247A1 (en) Anti-hair loss lotion
KR101618350B1 (en) Cosmetic or pharmaceutical composition for promoting hair growth containing 5-hydroxytryptophan
KR20040049068A (en) Hair growth promotion composition
KR20150085961A (en) Cosmetic or pharmaceutical composition for promoting hair growth containing Aloe-emodin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14814134

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14814134

Country of ref document: EP

Kind code of ref document: A1